FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

77703004: Amphotericin B (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
128963013 Amphotericin B en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
818563012 Amphotericin B (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2796861000005115 Amphotericin B da Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amphotericin B Is a Amphotericin-containing product false Inferred relationship Some
Amphotericin B Is a Amphotericin (substance) true Inferred relationship Some
Amphotericin B This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antifungal true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Accidental amphotericin B poisoning Causative agent False Amphotericin B Inferred relationship Some
Intentional amphotericin B poisoning Causative agent False Amphotericin B Inferred relationship Some
forgiftning med amphotericin B, uvist med hvilken hensigt Causative agent False Amphotericin B Inferred relationship Some 1
Amphotericin B measurement Has measured component False Amphotericin B Inferred relationship Some
Amphotericin measurement Has measured component False Amphotericin B Inferred relationship Some
Poisoning by amphotericin B Causative agent True Amphotericin B Inferred relationship Some 1
Amphotericin B measurement Component True Amphotericin B Inferred relationship Some 1
Amphotericin measurement Component False Amphotericin B Inferred relationship Some
Amphotericin b 50mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
amphotericin B 100 mg hætteglas pulver The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
Amphotericin B 30 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
Amphotericin b 50mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
amphotericin B 100 mg/ml suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
amphotericin B 5 mg infusionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
Amphotericin B liposome (substance) Is a False Amphotericin B Inferred relationship Some
Accidental amphotericin B poisoning Causative agent True Amphotericin B Inferred relationship Some 1
Intentional amphotericin B poisoning Causative agent True Amphotericin B Inferred relationship Some 1
Amphotericin B cholesteryl sulfate complex (substance) Is a False Amphotericin B Inferred relationship Some
Amphotericin B lipid complex (substance) Is a False Amphotericin B Inferred relationship Some
Intentional amphotericin B overdose Causative agent True Amphotericin B Inferred relationship Some 1
Accidental amphotericin B overdose Causative agent True Amphotericin B Inferred relationship Some 1
Amphotericin B overdose (disorder) Causative agent True Amphotericin B Inferred relationship Some 1
overdosis af amphotericin B, uvist med hvilken hensigt Causative agent False Amphotericin B Inferred relationship Some 1
amphotericin B 50 mg infusionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
Product containing amphotericin B (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Product containing amphotericin B in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Amphotericin B-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Product containing amphotericin B in topical dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amphotericin B Inferred relationship Some
Amphotericin B cholesteryl sulfate complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Amphotericin B Inferred relationship Some
Amphotericin B lipid complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Amphotericin B Inferred relationship Some
Amphotericin B liposome (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Amphotericin B Inferred relationship Some
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B Inferred relationship Some 1
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B Inferred relationship Some 1
Amphotericin B phospholipid complex (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Amphotericin B Inferred relationship Some
Amphotericin B 50 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B Inferred relationship Some 1
Amphotericin B 50 mg powder for solution for injection vial The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B Inferred relationship Some 1
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B Inferred relationship Some 1
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B Inferred relationship Some 1
Product containing amphotericin B in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Amphotericin B-containing product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Amphotericin B only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Product containing only amphotericin B (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Product containing only amphotericin B in cutaneous dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Product containing only amphotericin B in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Product containing only amphotericin B in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amphotericin B Inferred relationship Some 1
Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B Inferred relationship Some 1
Product containing precisely amphotericin B 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B Inferred relationship Some 1
Amphotericin B 30 mg/mL cutaneous cream This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B Inferred relationship Some 1
Amphotericin B 30 mg/mL cutaneous cream The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B Inferred relationship Some 1
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amphotericin B Inferred relationship Some 1
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amphotericin B Inferred relationship Some 1

This concept is not in any reference sets

Back to Start